Variant report
Variant | esv3361078 |
---|---|
Chromosome Location | chr12:12200900-12201151 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ELK1 | chr12:12201129-12201279 | Hela-S3 | cervix: | n/a | n/a |
2 | MYC | chr12:12200936-12200997 | MCF-7 | breast: | n/a | n/a |
3 | NR2C2 | chr12:12200540-12201328 | GM12878 | blood: | n/a | n/a |
4 | SP2 | chr12:12200681-12201205 | HepG2 | liver: | n/a | n/a |
5 | SUZ12 | chr12:12200663-12201040 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
BCL2L14 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs199991669 | chr12:12200900-12200901 | Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs111171413 | chr12:12200923-12200924 | Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs367565518 | chr12:12200929-12200930 | Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs111211776 | chr12:12200951-12200952 | Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs142589022 | chr12:12200981-12200982 | Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs63233260 | chr12:12200982-12200983 | Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs58782849 | chr12:12200984-12200985 | Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs11054635 | chr12:12200985-12200986 | Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs146747678 | chr12:12200995-12200996 | Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs538498010 | chr12:12200997-12200998 | Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs556958139 | chr12:12201000-12201001 | Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs149420654 | chr12:12201010-12201011 | Weak transcription Enhancers ZNF genes & repeats Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs569197318 | chr12:12201015-12201016 | Weak transcription Enhancers ZNF genes & repeats Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs61131079 | chr12:12201017-12201018 | Weak transcription Enhancers ZNF genes & repeats Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs536379908 | chr12:12201023-12201024 | Weak transcription Enhancers ZNF genes & repeats Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs200108797 | chr12:12201045-12201046 | Weak transcription Enhancers ZNF genes & repeats Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs2430594 | chr12:12201047-12201048 | Weak transcription Enhancers ZNF genes & repeats Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs555023119 | chr12:12201068-12201069 | Weak transcription Enhancers ZNF genes & repeats Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs150937774 | chr12:12201071-12201072 | Weak transcription Enhancers ZNF genes & repeats Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs58351353 | chr12:12201074-12201075 | Weak transcription Enhancers ZNF genes & repeats Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs143257485 | chr12:12201097-12201098 | Weak transcription Enhancers ZNF genes & repeats Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs71761536 | chr12:12201100-12201101 | Weak transcription Enhancers ZNF genes & repeats Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs146276061 | chr12:12201101-12201102 | Weak transcription Enhancers ZNF genes & repeats Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs202016490 | chr12:12201105-12201106 | Weak transcription Enhancers ZNF genes & repeats Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs563260306 | chr12:12201120-12201121 | Weak transcription Enhancers ZNF genes & repeats Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs111545048 | chr12:12201136-12201137 | Weak transcription Enhancers ZNF genes & repeats Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs373957315 | chr12:12201137-12201138 | Weak transcription Enhancers ZNF genes & repeats Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs532230293 | chr12:12201150-12201151 | Weak transcription Enhancers ZNF genes & repeats Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 17690704 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Breast cancer | 22032731 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 21965145 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Prostate cancer | 19156837 | CNVD |
Emphysema | 19352772 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Malignant germ cell tumour | 17285132 | CNVD |
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21611746 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16461572 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:12199200-12209200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr12:12199400-12201000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr12:12200200-12201400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr12:12200200-12201600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr12:12200200-12201600 | Enhancers | HepG2 | liver |
6 | chr12:12200200-12213600 | Weak transcription | Right Atrium | heart |
7 | chr12:12200600-12201000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr12:12200600-12201000 | Flanking Active TSS | Breast Myoepithelial Primary Cells | Breast |
9 | chr12:12200600-12201000 | Enhancers | Fetal Kidney | kidney |
10 | chr12:12200600-12201200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr12:12201000-12201200 | Active TSS | Breast Myoepithelial Primary Cells | Breast |
12 | chr12:12201000-12201800 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |